Viking Therapeutics (VKTX) is up 8.9% today. Here is some analysis on what might have caused this price movement
Analysis: The rally appears to be driven by renewed optimism around Viking’s obesity pipeline rather than a single major same-day corporate announcement. Recent momentum includes the June launch of a Phase 1 study for VK3019, ongoing Phase 3 development for VK2735, and a fresh analyst reiteration highlighting upcoming maintenance-study data as a potential catalyst
Sources:
Viking Therapeutics, SEC, Investing.com
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes
$VKTX Insider Trading Activity
$VKTX insiders have traded $VKTX stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales
Here’s a breakdown of recent trading of $VKTX stock by insiders over the last 6 months:
- NEIL WILLIAM AUBUCHON (Chief Commercial Officer) purchased 4,475 shares for an estimated $149,912
To track insider transactions, check out Quiver Quantitative’s insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint
Quiver Alerts
Receive VKTX Data Alerts
Get market-moving data, filings, and signals for VKTX in real time.
Sign Up
$VKTX Hedge Fund Activity
We have seen 177 institutional investors add shares of $VKTX stock to their portfolio, and 169 decrease their positions in their most recent quarter
Here are some of the largest recent moves:
- TWO SIGMA INVESTMENTS, LP added 1,996,405 shares (+82.0%) to their portfolio in Q1 2026, for an estimated $64,963,018
- AMERICAN CENTURY COMPANIES INC added 1,773,211 shares (+580.7%) to their portfolio in Q1 2026, for an estimated $57,700,285
- RAYMOND JAMES FINANCIAL INC added 1,153,405 shares (+125.1%) to their portfolio in Q1 2026, for an estimated $37,531,798
- VESTAL POINT CAPITAL, LP added 914,147 shares (+inf%) to their portfolio in Q1 2026, for an estimated $29,746,343
- JANE STREET GROUP, LLC removed 752,168 shares (-50.1%) from their portfolio in Q1 2026, for an estimated $24,475,546
- SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 718,022 shares (-50.4%) from their portfolio in Q1 2026, for an estimated $23,364,435
- EXODUSPOINT CAPITAL MANAGEMENT, LP removed 652,572 shares (-90.4%) from their portfolio in Q1 2026, for an estimated $21,234,692
To track hedge funds’ stock portfolios, check out Quiver Quantitative’s institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint
$VKTX Price Targets
Multiple analysts have issued price targets for $VKTX recently. We have seen 4 analysts offer price targets for $VKTX in the last 6 months, with a median target of $101.0
Here are some recent targets:
- Daniel Brims from Lake Street set a target price of $89.0 on 05/28/2026
- Jeet Mukherjee from BTIG set a target price of $125.0 on 05/01/2026
- Steve Seedhouse from Cantor Fitzgerald set a target price of $100.0 on 04/30/2026
- Joseph Pantginis from HC Wainwright & Co. set a target price of $102.0 on 03/23/2026
This article is not financial advice. See Quiver Quantitative’s disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies
